Structure of organic molecules — stereochemistry

Intuition [Beginner]

Some molecules are not the same as their mirror image. Hold up your two hands: the left hand is the mirror image of the right, but no rotation in three dimensions makes them coincide. The same thing happens with molecules. A carbon atom bonded to four different groups has two mirror-image forms called enantiomers, and those two forms are as non-interchangeable as your left and right hands.

This property -- having non-superimposable mirror images -- is called chirality. A carbon with four different groups is a stereocentre (also called a chiral centre). Most biological molecules are chiral: amino acids in proteins are one enantiomer, sugars in DNA and RNA are the other. The wrong enantiomer of a drug can be inactive or harmful. Thalidomide is the canonical caution: one enantiomer is a sedative, the other causes birth defects.

Enantiomers have identical physical properties in an achiral environment (same boiling point, same solubility) but differ in one measurable way: they rotate plane-polarised light in opposite directions. This is optical activity. A sample of only one enantiomer rotates the plane of light clockwise or counterclockwise; the other enantiomer rotates it by the same amount in the opposite direction. A 50:50 mix of both enantiomers (a racemate) has zero net rotation.

When a molecule has two stereocentres, more possibilities open up. The four groups at each centre can be arranged independently, giving up to $2^n$ distinct stereoisomers for $n$ stereocentres. But sometimes two of those arrangements are the same molecule -- if the molecule has an internal mirror plane, the "two" enantiomers are actually identical. Such a compound is called a meso compound: it has stereocentres but is achiral overall because the internal mirror plane makes it superimposable on its own mirror image.

Visual [Beginner]

Picture a tetrahedral carbon at the centre of a tetrahedron. Four different groups sit at the four vertices: a hydrogen, a methyl group, a hydroxyl group, and an amino group, say.

Enantiomers. Build the mirror image by reflecting through any plane. The original tetrahedron and its mirror image cannot be rotated to coincide. They are enantiomers. The relationship is binary: two molecules are either enantiomers or they are not.

Diastereomers. Now build a second tetrahedral carbon somewhere in the same molecule, also with four different groups. Flip the configuration at just one of the two centres while leaving the other alone. The resulting molecule is a diastereomer of the original: the two molecules are stereoisomers (same connectivity, different 3D arrangement) but they are not mirror images. Diastereomers have different physical properties -- different melting points, different solubilities -- unlike enantiomers.

Meso compound. Connect two identical chiral carbons by a chain that allows a mirror plane through the middle of the molecule. Arrange one carbon as R and the other as S. The internal mirror plane makes the whole molecule achiral: it has stereocentres, but the molecule as a whole is superimposable on its mirror image, and it does not rotate plane-polarised light.

Worked example [Beginner]

Assigning R/S to alanine's stereocentre.

Alanine is the amino acid ${\text{H}}_2\text{N}{\text{-CH(CH}}_3\text{)-COOH}$. The central carbon is bonded to four different groups: ${\text{-NH}}_2$, $\text{-COOH}$, ${\text{-CH}}_3$, and $\text{-H}$. This is a stereocentre.

Step 1. Assign CIP priorities. The Cahn-Ingold-Prelog rules rank by atomic number of the atom directly bonded to the stereocentre: N (7) > C (6) > H (1). Both $\text{-COOH}$ and ${\text{-CH}}_3$ attach through carbon, so we go one bond further out. For $\text{-COOH}$ the next atoms are O, O, and the C of the carbonyl (oxygen outranks carbon). For ${\text{-CH}}_3$ the next atoms are H, H, H. Oxygen beats hydrogen, so $\text{-COOH}$ outranks ${\text{-CH}}_3$.

Priority order: ${\text{-NH}}_2$ (1) > $\text{-COOH}$ (2) > ${\text{-CH}}_3$ (3) > $\text{-H}$ (4).

Step 2. Orient the molecule so the lowest-priority group ($\text{-H}$) points away from you, behind the plane of the page.

Step 3. Read the remaining three groups 1 $\to$ 2 $\to$ 3. If the path traces a clockwise arc, the configuration is R (Latin rectus, right). If counterclockwise, it is S (Latin sinister, left).

For L-alanine (the form found in proteins), tracing ${\text{-NH}}_2\to \text{-COOH}\to {\text{-CH}}_3$ goes counterclockwise, so L-alanine is (S)-alanine.

Drawing stereoisomers of 2,3-dibromobutane and identifying the meso form.

2,3-Dibromobutane: ${\text{CH}}_3{\text{-CHBr-CHBr-CH}}_3$. Two stereocentres (C2 and C3). Maximum four stereoisomers ($2^2=4$), but symmetry may reduce this.

Draw the four combinations. Use wedge/dash notation.

1. (2R, 3R): both bromines on the same side (wedge-wedge). This is one enantiomer.
2. (2S, 3S): both bromines on the same side (dash-dash). Mirror image of (2R,3R). The other enantiomer.
3. (2R, 3S): bromines on opposite sides (wedge at C2, dash at C3).
4. (2S, 3R): bromines on opposite sides (dash at C2, wedge at C3).

But structures 3 and 4 are the same molecule. Rotating (2R,3S) by 180 degrees about the C2-C3 bond gives (2S,3R). The molecule has an internal mirror plane bisecting the C2-C3 bond: the two halves are mirror images. This is the meso form. It has stereocentres but is achiral overall, with zero optical rotation.

Result: three stereoisomers. A pair of enantiomers ((2R,3R) and (2S,3S)) plus one meso compound ((2R,3S) = (2S,3R)).

What this tells us: the maximum $2^n$ count is reduced by molecular symmetry. Identifying meso forms requires checking for internal mirror planes or inversion centres.

Check your understanding [Beginner]

Formal definition [Intermediate+]

Let a molecule $M$ be represented as a labelled graph $G=(V,E,\ell )$ where $V$ is the set of atoms, $E$ the set of bonds, and $\ell :V\to \mathcal{A}$ assigns element labels from a periodic table $\mathcal{A}$. The molecular graph records connectivity (which atoms are bonded to which) and bond order but not three-dimensional arrangement.

A constitutional isomer of $M$ is a molecule with the same molecular formula but different connectivity -- a different graph with the same vertex labels and total edge weights. A stereoisomer of $M$ is a molecule with the same connectivity graph but a different spatial arrangement of atoms.

Chirality. A molecule is chiral if it is not superimposable on its mirror image. Formally, let $\sigma$ denote a reflection through an arbitrary plane. A molecule with nuclear coordinates $\{r_i\}$ is chiral if no proper rotation $R\in \mathrm{SO}(3)$ exists such that $R\sigma \{r_i\}=\{r_i\}$. Equivalently, the molecule's point group lacks any improper rotation axis $S_n$ (including the special cases $S_1=\sigma$ and $S_2=i$).

Stereocentre. A tetrahedral atom bonded to four different substituent groups is a stereogenic centre (stereocentre). "Different" is determined by the CIP ranking: two substituents are identical only if their entire substituent trees (recursive atomic-number comparisons outward from the stereocentre) are identical. A stereogenic centre has exactly two configurations, related by inversion.

CIP priority rules. The Cahn-Ingold-Prelog system assigns an unambiguous priority ranking to the four substituents of a stereocentre:

1. Rank by atomic number of the atom directly bonded to the stereocentre. Higher atomic number = higher priority.
2. If two atoms have the same atomic number, expand one bond further and compare the atomic numbers of the second-shell atoms, sorted in descending order. Compare element by element.
3. Continue recursively until a difference is found. Double bonds are treated as two single bonds to phantom duplicate atoms.

R/S assignment. Orient the molecule so the lowest-priority group (4) points away from the observer. Trace the arc from group 1 to 2 to 3. Clockwise = R (rectus). Counterclockwise = S (sinister).

E/Z assignment (alkenes). For a double bond C${}_a$=C${}_b$, assign CIP priorities separately at each carbon. At C${}_a$, the two substituents are ranked $a_1>a_2$. At C${}_b$, ranked $b_1>b_2$. If the two higher-priority substituents ($a_1$ and $b_1$) are on the same side of the double bond, the configuration is Z (zusammen, together). If on opposite sides, E (entgegen, opposite). The E/Z system replaces the older cis/trans notation, which is ambiguous when more than two substituent types are present.

Enantiomers. Two molecules that are mirror images but not superimposable. Every stereocentre in one enantiomer has the inverted configuration (R to S, S to R) relative to the other.

Diastereomers. Two stereoisomers that are not enantiomers. Diastereomers differ at one or more (but not all) stereocentres. They have different physical properties (melting point, boiling point, solubility, chromatographic retention).

Meso compound. A molecule with stereocentres that is achiral overall because it possesses an improper symmetry element (a mirror plane or inversion centre). The stereocentres are present but their optical effects cancel by internal symmetry. A meso compound has zero optical rotation.

Optical activity. A chiral substance rotates the plane of linearly polarised light. The specific rotation $[\alpha ]$ is defined as

$$[\alpha {]}_{\lambda }^T=\frac{\alpha }{c\cdot l},$$

where $\alpha$ is the observed rotation in degrees, $c$ is concentration in g/mL, and $l$ is path length in decimetres. The sign convention: clockwise rotation (as viewed facing the light source) is dextrorotatory (+); counterclockwise is levorotatory (-). There is no general correspondence between R/S configuration and +/- rotation direction; they are independent assignments.

Counterexamples to common slips

• "Chiral means R or S." R/S describes the configuration at a single stereocentre. Chirality is a property of the entire molecule. A molecule with multiple stereocentres can be R at one and S at another and still be chiral overall. Conversely, a meso compound has R and S centres but is achiral.
• "Four different groups always means chiral." True only for a single stereocentre in isolation. A molecule with two stereocentres can have an internal mirror plane (meso) and be achiral despite having four different groups at each centre.
• "Cis and trans always work for double bonds." Cis/trans presuppose that each carbon of the double bond carries exactly two named substituent types (e.g., cis = same side for two identical groups). When three or four different groups are present, cis/trans is undefined and E/Z is required.
• "Enantiomers have different physical properties." Enantiomers have identical physical properties in an achiral environment (melting point, boiling point, NMR spectrum). They differ only in their interaction with other chiral entities (plane-polarised light, chiral stationary phases, biological receptors).

Key theorem with proof [Intermediate+]

Proposition (Maximum number of stereoisomers). A molecule with $n$ stereogenic centres has at most $2^n$ stereoisomers. The actual number equals $2^n$ if and only if no meso forms exist (i.e., no combination of R/S assignments produces a molecule with an improper symmetry element).

Proof. Each stereogenic centre has exactly two configurations (R or S). The configuration choices are independent across centres: choosing R or S at centre $i$ does not constrain the choice at centre $j\ne i$ in terms of connectivity. So there are $2^n$ formal combinations of R/S assignments, each yielding a distinct molecular graph with definite stereochemistry.

The actual number of distinct stereoisomers is $2^n$ minus the number of pairs of formal assignments that produce the same molecule. Two assignments produce the same molecule when the molecule has an internal symmetry operation (mirror plane or inversion centre) that maps one assignment to the other. This happens precisely when a meso form exists: an R,S assignment at two centres related by an internal mirror plane produces the same molecule as the S,R assignment at those same centres.

For a molecule with $n$ centres and $m$ internal mirror planes, each plane reduces the count by at most $2^{n-2}$ (pairing the two centres related by the plane), but the combinatorics depend on the specific substitution pattern. The upper bound $2^n$ is tight (achieved when all centres are inequivalent and no meso forms exist). The lower bound is 1 for a fully meso molecule. $■$

Corollary. For 2,3-dibromobutane ($n=2$), the four formal combinations (RR, SS, RS, SR) give three distinct stereoisomers: RR/SS are an enantiomeric pair, and RS = SR is a single meso compound. The count $3=2^2-1$ reflects one meso reduction.

The stereoisomer counting theorem is the first combinatorial result in stereochemistry. It connects the local geometry of tetrahedral carbon (two configurations per centre) to the global molecular symmetry that may or may not identify some of those combinations.

Bridge. The stereoisomer counting theorem builds toward 15.04.02 pending where the stereochemical consequences of reaction mechanisms are quantified: SN2 produces clean inversion at the reacting stereocentre (one binary switch flipped) while SN1 produces racemisation (the switch randomised). This is exactly the structural reason that mechanism stereochemistry is diagnostic — each stereocentre acts as an independent binary probe of the reaction pathway, and the pattern of retention, inversion, or scrambling across all centres identifies the mechanism unambiguously. The foundational reason the theorem works is that sp${}^3$ tetrahedral geometry admits exactly two non-superimposable configurations per centre, and the central insight is that internal symmetry operations are the only mechanism that can reduce the maximum $2^n$ count.

Exercises [Intermediate+]

Chirality beyond tetrahedral carbon [Master]

Tetrahedral stereocentres are the most common but not the only source of chirality. Several structural motifs produce non-superimposable mirror images without any carbon bearing four different groups. These extended chirality types -- axial, planar, and helical -- are essential in asymmetric catalysis, materials science, and drug design, where many of the most effective chiral ligands and pharmaceuticals derive their handedness from an axis or helix rather than a tetrahedral centre.

Allenes and axial chirality. A cumulated diene C=C=C has two perpendicular $\pi$-systems at the terminal carbons. The central carbon is sp-hybridised, and the two substituent planes at the termini are mutually perpendicular. When each terminal carbon bears two different substituents (e.g., 1,3-dimethylallene, ${\text{CH}}_3{\text{-CH=C=CH-CH}}_3$ with different substituent pairs at each end), the molecule is chiral despite having no tetrahedral stereocentre. The chirality axis is the central sp-hybridised carbon, and the two enantiomers differ in the handedness of the propeller-like arrangement of the perpendicular planes.

The stereochemical descriptor for allenes uses a modified CIP-based rule: view along the chirality axis from one end, and trace the arc from the higher-priority substituent on the near carbon to the higher-priority substituent on the far carbon. Clockwise gives $P$ (plus) helicity; counterclockwise gives $M$ (minus) helicity. This $P/M$ (or $\Delta /\Lambda$) notation extends to any axially chiral system and is the standard in coordination chemistry and inorganic stereochemistry.

The enantiomerisation barrier for simple allenes is extremely high (the allene would need to pass through a linear transition state that breaks the perpendicular arrangement), so allenes are configurationally stable at room temperature. However, substituted allenes with small groups at the termini can undergo thermal racemisation through a bent-allene transition state at elevated temperatures.

Axially chiral biaryls and atropisomerism. Two aromatic rings joined by a single bond can have restricted rotation if large substituents flanking the bond create a steric barrier to free rotation. If the two rings are differently substituted, the molecule is chiral. The chirality axis is the biaryl bond. The resulting stereoisomers are called atropisomers (from Greek a-tropos, "not turning") when the barrier to interconversion is high enough that they can be isolated.

The canonical example is BINOL (1,1'-bi-2-naphthol), in which two naphthol units are linked at the 1-positions. The peri-hydrogens (at the 8-positions of each naphthyl ring) create a steric clash that prevents the two rings from becoming coplanar. The molecule exists as two stable atropisomers: (R)-BINOL and (S)-BINOL, with a rotational barrier of approximately 37 kcal/mol at room temperature. BINOL and its phosphine analogue BINAP (2,2'-bis(diphenylphosphino)-1,1'-binaphthyl) are among the most widely used chiral ligands in asymmetric catalysis. The Noyori asymmetric hydrogenation, which won the 2001 Nobel Prize, uses BINAP-Ru complexes to hydrogenate prochiral olefins with enantiomeric excess routinely above 95% ^[Noyori2002].

The atropisomeric barrier depends on the size of the ortho substituents and the length of the connecting bond. A conventional threshold for "stable atropisomer" is a racemisation half-life exceeding 1000 seconds at room temperature, corresponding to a rotational barrier of roughly 22--24 kcal/mol. Below this barrier, the atropisomers interconvert too rapidly for practical resolution. The barrier can be tuned by substituent choice: larger ortho groups raise the barrier, electron-donating groups on one ring paired with electron-accepting groups on the other can lower it by stabilising a coplanar transition state.

Helically chiral molecules. A helix is chiral by definition: a right-handed helix is the mirror image of a left-handed helix and the two are not superimposable. Helicenes (benzene rings fused in an overlapping spiral) are inherently chiral with no stereocentre and no chirality axis -- the helix itself is the chirality element. [6]Helicene (six ortho-fused benzene rings) has a racemisation barrier of approximately 37 kcal/mol, high enough for configurational stability at room temperature.

Helicenes display intense optical activity: [6]helicene has $[\alpha {]}_D\approx -3640^{\circ }$ (for the M-enantiomer), among the largest specific rotations known for organic molecules. This extreme optical rotation arises from the extended $\pi$-system's helical twist, which couples strongly to the electric and magnetic components of circularly polarised light. Helicene-derived ligands have been used in asymmetric catalysis, and helicenes themselves have been investigated as circularly-polarised-light-emitting materials for display technology.

Planar chirality. A dissymmetric group attached to a planar, symmetric ring can create chirality when the attachment point is not the only distinguishing feature. The canonical example is [2.2]paracyclophane, a molecule in which two benzene rings are bridged by two-carbon chains on opposite sides, forcing the rings into close parallel proximity. When one ring carries a single substituent, the molecule is chiral: the chirality plane is the substituted ring, and the orientation of the substituent relative to the second ring determines the handedness.

Ferrocene derivatives provide another example of planar chirality. Ferrocene itself ($\text{Fe}({\text{C}}_5{\text{H}}_5{)}_2$) has two parallel cyclopentadienyl (Cp) rings. If one Cp ring carries two different substituents in a 1,2-pattern, the molecule is chiral: the plane of the substituted ring is the chirality plane, and the spatial relationship of the two substituents to the other Cp ring creates non-superimposable mirror images. Ferrocene-based planar-chiral ligands (e.g., Josiphos) are used industrially in asymmetric hydrogenation for pharmaceutical synthesis.

These extended chirality types share a common structural feature: the molecule lacks any improper symmetry operation ($S_n$, $\sigma$, or $i$). The test for chirality is always the same -- check for improper symmetry -- regardless of whether the source is a tetrahedral centre, an axis, a helix, or a plane. The distinction between centre, axis, helix, and plane chirality is descriptive, not fundamental: all reduce to the absence of an $S_n$ operation.

Prochirality and topicity [Master]

A carbon bearing two identical groups and two different groups is not a stereocentre, but it becomes one if one of the identical groups is replaced. Such a carbon is prochiral. The two identical groups are enantiotopic: replacing one produces the R enantiomer, replacing the other produces the S enantiomer. Enantiotopic groups are distinguished by the CIP system applied to the putative stereocentre formed by replacing each identical group in turn with a phantom atom of higher priority than the existing groups.

The concept extends to trigonal centres (sp${}^2$ carbons). A carbonyl group $\text{C=O}$ has two faces. If the three substituents at the carbonyl carbon are all different (or if the molecule is already chiral elsewhere), the two faces are distinct. The Re/Si face designation assigns CIP priorities to the three substituents, then views the face: if the arc 1-2-3 is clockwise, the face is Re (rectus); if counterclockwise, Si (sinister). This designation is the prochiral analogue of R/S for tetrahedral centres and is essential for describing the stereochemical course of nucleophilic additions to carbonyls.

In an achiral environment, enantiotopic groups are chemically equivalent (same reaction rate, same NMR chemical shift). In a chiral environment (a chiral solvent, a chiral catalyst, or an enzyme active site), enantiotopic groups become chemically distinct. This is the basis of enzymatic stereoselectivity: an enzyme treats the two faces of a prochiral carbonyl or the two hydrogens on a prochiral methylene differently, yielding one enantiomer selectively. Alcohol dehydrogenase, for example, transfers hydride from NADH to the Re face of acetaldehyde exclusively, producing (R)-ethanol with complete facial selectivity.

The topicity classification organises the relationship between pairs of identical groups in a molecule:

• Homotopic groups: related by a proper rotation ($C_n$). Replacement of either gives the same product. Homotopic groups are chemically equivalent in all environments and have identical NMR shifts. Test: replace each with a test atom; if the two resulting structures are identical (superimposable by proper rotation), the groups are homotopic.
• Enantiotopic groups: related by an improper rotation ($S_n$, i.e., a mirror plane or inversion centre) but not by any proper rotation. Replacement of either gives enantiomers. Enantiotopic groups are equivalent in achiral environments but distinct in chiral environments. Test: replacement gives enantiomers.
• Diastereotopic groups: not related by any symmetry operation. Replacement gives diastereomers. Diastereotopic groups are chemically distinct in all environments and have different NMR chemical shifts even in achiral solvents.

The practical importance of topicity is most visible in NMR spectroscopy. The two protons on a ${\text{-CH}}_2\text{-}$ group adjacent to a stereocentre are diastereotopic and appear as two distinct signals (an AB quartet pattern) rather than a single peak. This diastereotopic splitting is one of the most common diagnostic features in proton NMR of chiral molecules and is the direct experimental evidence that "identical" groups in different stereochemical environments are not chemically identical.

The Re/Si face designation connects prochirality to reaction stereochemistry. When a nucleophile attacks the Re face of a prochiral ketone, the resulting alcohol has one configuration; Si-face attack gives the other. The facial selectivity of the attack is governed by the transition-state geometry, which in turn is influenced by steric and electronic interactions between the nucleophile and the substituents around the carbonyl. Cram's rule (and its modern refinement, the Felkin-Anh model) predicts which face is preferred based on the relative sizes of the three substituents. The Felkin-Anh model places the largest substituent perpendicular to the carbonyl plane, and the nucleophile approaches from the side of the smallest substituent -- the trajectory that minimises steric repulsion in the transition state.

Asymmetric synthesis and resolution [Master]

Preparing a single enantiomer of a chiral compound is the central practical problem of stereochemistry. Two broad approaches exist: resolving a racemic mixture into its components, or building the stereocentre with the desired configuration from achiral starting materials.

Resolution separates enantiomers from a racemic mixture. Pasteur's original method (manual crystal sorting, 1848) is historically important but impractical at scale ^{[Pasteur1848]}. Modern methods include: diastereomeric salt formation (react the racemate with a chiral resolving agent to form diastereomeric salts with different solubilities, then crystallise selectively); chromatography on a chiral stationary phase (the two enantiomers have different retention times on a column packed with a chiral material); kinetic resolution (a chiral catalyst reacts faster with one enantiomer, depleting it from the mixture); and enzymatic resolution (enzymes are inherently chiral and often react with only one enantiomer).

The theoretical yield of any single-step resolution is 50% (half the material is the wrong enantiomer). Dynamic kinetic resolution can exceed this limit by racemising the unwanted enantiomer in situ while the desired one is selectively consumed, driving the yield toward 100%. The racemisation catalyst operates concurrently with the enantioselective reaction, continuously feeding the substrate pool with racemic material that the chiral catalyst then resolves.

Asymmetric synthesis builds the stereocentre with the desired configuration from achiral starting materials, avoiding the 50% yield ceiling of resolution. The major approaches are:

Chiral auxiliaries. A chiral temporary group is attached to the substrate, directing the reaction through steric or electronic control, then removed after the stereocentre is formed. The Evans oxazolidinone auxiliary is the canonical example: an enolate bearing the chiral oxazolidinone undergoes alkylation preferentially from one face, giving a single diastereomer in high yield. The auxiliary is removed by hydrolysis, revealing the product with the desired absolute configuration. Chiral auxiliaries are reliable and predictable but require two extra steps (attachment and removal) and consume stoichiometric quantities of the auxiliary.

Chiral catalysts. Transition-metal complexes with chiral ligands catalyse enantioselective transformations at the stereocentre-forming step. The three Nobel-Prize-winning examples from 2001 illustrate the range:

The Knowles asymmetric hydrogenation (1975) used a Rh complex with the chiral phosphine ligand DIPAMP to hydrogenate a prochiral enamide to L-DOPA, a drug for Parkinson's disease, with 94% ee ^{[Knowles2002]}. The chiral Rh centre differentiates the two enantiotopic faces of the prochiral double bond: the substrate coordinates to the metal through one preferred orientation, and hydrogen is delivered from one face selectively.

The Noyori asymmetric hydrogenation uses BINAP-Ru complexes to hydrogenate a broader range of prochiral substrates (beta-keto esters, olefins, ketones) with enantioselectivities routinely exceeding 95% and often reaching above 99% ^[Noyori2002]. The BINAP ligand's axially chiral binaphthyl framework creates a well-defined chiral pocket around the ruthenium centre. The substrate coordinates in the pocket with one preferred orientation, and hydrogen transfer occurs on one face.

The Sharpless asymmetric epoxidation (1980) converts allylic alcohols to epoxides using titanium tetraisopropoxide, diethyl tartrate (DET), and tert-butyl hydroperoxide ^{[Sharpless2002]}. The chirality of the product is determined by the chirality of the tartrate: (R,R)-DET gives one enantiomer, (S,S)-DET gives the other, with enantioselectivities typically above 90%. The Sharpless model predicts facial selectivity from the allylic alcohol geometry: the hydroxyl group coordinates to titanium, positioning the double bond for approach from one face.

Substrate-controlled diastereoselectivity. An existing stereocentre biases the formation of a new one through steric interactions in the transition state. Cram's rule and the Felkin-Anh model predict the major product of nucleophilic addition to a chiral aldehyde or ketone. The existing stereocentre defines which face of the carbonyl is more accessible to the nucleophile. This is an internal stereocontrol mechanism -- the chirality is already in the substrate, not in an external reagent.

Enzymatic asymmetric synthesis. Enzymes are nature's chiral catalysts, operating with exquisite facial selectivity under mild conditions. Lipases, esterases, and ketoreductases are widely used in industrial asymmetric synthesis. The advantage is near-perfect enantioselectivity (often above 99% ee) under aqueous, ambient conditions; the limitation is that each enzyme is highly substrate-specific and may not tolerate the structural diversity required for a given synthetic route.

The quantitative measure of asymmetric synthesis success is the enantiomeric excess (ee), defined as $\text{ee}=|(\text{major}-\text{minor})|/(\text{major}+\text{minor})\times 100\%$. A racemic mixture has ee = 0%; a single enantiomer has ee = 100%. The ee is measured experimentally by chiral HPLC (separating the two enantiomers on a chiral column and integrating the peak areas), by polarimetry (comparing the observed specific rotation to the literature value for the pure enantiomer), or by NMR with chiral shift reagents (which render the two enantiomers diastereomeric in the NMR spectrum).

Dynamic stereochemistry and atropisomerism [Master]

Static stereochemistry classifies molecules by their three-dimensional arrangement at equilibrium. Dynamic stereochemistry addresses the interconversion between stereoisomers: the barriers to rotation, inversion, and racemisation, and the kinetics of those processes. This framework is essential for understanding molecular chirality as a dynamic property that depends on temperature and timescale, not just on connectivity.

Atropisomerism in detail. Atropisomers are stereoisomers that interconvert by rotation about a single bond. The interconversion barrier $\Delta G_{\text{rot}}^{‡}$ determines whether the atropisomers are configurationally stable on the experimental timescale. The racemisation rate constant is $k_{\text{rac}}=2k_{\text{inv}}$ (the factor of 2 arises because each rotation event can produce either enantiomer), and the half-life for racemisation is:

$$t_{1/2}=\frac{\ln 2}{k_{\text{rac}}}=\frac{\ln 2}{2k_{\text{inv}}}.$$

By the Eyring equation, $k_{\text{inv}}=(k_{B}T/h)\exp (-\Delta G_{\text{rot}}^{‡}/RT)$. At 298 K, the prefactor $k_{B}T/h\approx 6.21\times 10^{12}{\text{s}}^{-1}$. A barrier of $\Delta G_{\text{rot}}^{‡}=24$ kcal/mol gives:

$$k_{\text{inv}}=6.21\times 10^{12}\times \exp (-24000/(1.987\times 298))\approx 6.21\times 10^{12}\times e^{-40.6}\approx 2.0\times 10^{-5}{\text{s}}^{-1},$$

corresponding to $t_{1/2}\approx 4.8$ hours -- stable enough for isolation on the bench. A barrier of 18 kcal/mol gives $t_{1/2}\approx 0.02$ seconds at 298 K, too fast for isolation. The 22--24 kcal/mol range (roughly 1000 s half-life at room temperature) is the conventional boundary between configurationally stable atropisomers and rapidly interconverting conformers.

Drug design applications. Atropisomerism is increasingly important in pharmaceutical chemistry. Atorvastatin (Lipitor), the best-selling drug in history, contains a biaryl linkage that gives rise to atropisomerism, although the barrier is low enough that interconversion is fast at body temperature and the atropisomerism is not pharmacologically relevant. Other drug candidates have higher rotational barriers: the kinase inhibitor venetoclax has a measured atropisomeric barrier of approximately 29 kcal/mol, giving a racemisation half-life of several years at room temperature. For such molecules, the two atropisomers are effectively separate chemical entities with potentially different pharmacological properties, and the FDA requires separate characterisation of each atropisomer if the interconversion half-life exceeds the dosing interval.

The vancomycin family of antibiotics presents an extreme case: the biaryl linkage between the aromatic amino acid residues is locked by multiple macrocyclic crosslinks, and the atropisomeric barrier exceeds 50 kcal/mol. The biaryl axis has a fixed absolute configuration in all biologically active vancomycin-class antibiotics, and disruption of this axis (by breaking the crosslinks) destroys the antibiotic activity.

Conformational enantiomers. Some molecules are chiral not because of a stereocentre or an axis, but because a conformational preference creates a helical structure. trans-Cyclooctene is a classic example: the ring strain forces the double bond into a twisted geometry that is inherently chiral. The (E)-isomer of cyclooctene exists as two conformational enantiomers with a racemisation barrier of approximately 35 kcal/mol (the ring must pass through a high-energy planar transition state). trans-Cyclooctene is the smallest cyclic alkene that is chiral at room temperature, and it is a potent chiral dienophile in asymmetric Diels-Alder reactions.

Sparteine, a naturally occurring alkaloid, is chiral because its rigid tetracyclic skeleton adopts a helical conformation. (-)-Sparteine is used as a chiral ligand in asymmetric deprotonation reactions, where it directs the base to remove one specific proton from a prochiral methylene group.

Racemisation kinetics. The racemisation of a chiral compound follows first-order kinetics in the enantiomeric excess:

$$\frac{d(\text{ee})}{dt}=-k_{\text{rac}}\cdot \text{ee}.$$

The ee decays exponentially: $\text{ee}(t)=\text{ee}(0)\exp (-k_{\text{rac}}t)$. The rate constant $k_{\text{rac}}$ depends on the racemisation mechanism. For inversion at nitrogen (e.g., amine racemisation), the barrier is typically 5--10 kcal/mol (fast at room temperature, $t_{1/2}$ in microseconds to seconds). For rotation about a hindered biaryl bond, the barrier is 20--40 kcal/mol. For pyramidal inversion at phosphorus in phosphines, the barrier is typically 30--35 kcal/mol, making many chiral phosphines configurationally stable.

The temperature dependence of $k_{\text{rac}}$ provides the activation parameters $\Delta H^{‡}$ and $\Delta S^{‡}$ through the Eyring equation. A positive $\Delta S^{‡}$ indicates a dissociative or loosening transition state (bonds partially broken), while a negative $\Delta S^{‡}$ indicates a tightening or associative transition state. For atropisomerism, the transition state involves the two rings passing through a coplanar arrangement, and $\Delta S^{‡}$ is typically small and negative because the coplanar arrangement is more ordered than the twisted ground state.

Stereospecificity, stereoselectivity, and enantiopurity [Master]

The terminology of stereochemical outcomes in chemical reactions is precise and hierarchical. Confusing these terms is one of the most common errors in the organic chemistry literature, and the distinctions matter because they have different mechanistic implications.

Stereospecific reactions. A reaction is stereospecific if different stereoisomeric starting materials give different stereoisomeric products (or, in the extreme case, one stereoisomer reacts and the other does not). SN2 substitution is stereospecific: the (R)-substrate gives the (S)-product and the (S)-substrate gives the (R)-product. The reaction is said to proceed with inversion of configuration -- a definite, predictable stereochemical outcome that is a necessary consequence of the backside-attack mechanism. If a reaction claimed to be SN2 were found to give retention, the mechanism assignment would be wrong.

E2 elimination is stereospecific in requiring an anti-periplanar arrangement of the leaving group and the abstracted hydrogen. For a substrate with defined stereochemistry, this geometric requirement dictates which hydrogen is removed and therefore the E/Z geometry of the resulting alkene.

Stereoselective reactions. A reaction is stereoselective if it produces one stereoisomer (or set of stereoisomers) in preference to others from the same starting material. The preference is quantitative, not absolute. An enantioselective reaction produces one enantiomer preferentially from an achiral starting material (measured by enantiomeric excess, ee). A diastereoselective reaction produces one diastereomer preferentially (measured by diastereomeric excess, de).

The distinction: stereospecificity is a mechanistic property (the stereochemical outcome is determined by the starting material's configuration), while stereoselectivity is a kinetic property (one pathway is faster than another). A reaction can be both stereospecific and stereoselective, or one without the other.

Enantiomeric excess (ee) and its measurement. The enantiomeric excess quantifies the purity of a chiral sample:

$$\text{ee}=\frac{[R]-[S]}{[R]+[S]}\times 100\%=\frac{[\alpha {]}_{\text{obs}}}{[\alpha {]}_{\text{pure}}}\times 100\%,$$

where $[R]$ and $[S]$ are the concentrations of the two enantiomers, $[\alpha {]}_{\text{obs}}$ is the measured specific rotation, and $[\alpha {]}_{\text{pure}}$ is the specific rotation of the pure enantiomer. The ee is independent of concentration and path length (both cancel in the ratio), making it a robust measure.

The three principal methods for measuring ee are:

Chiral HPLC. A column packed with a chiral stationary phase (typically a silica-bound derivative of cellulose, amylose, or a cyclodextrin) separates the two enantiomers by differential adsorption. The enantiomers have different affinities for the chiral stationary phase (a diastereomeric interaction) and elute at different retention times. The ee is calculated directly from the integrated peak areas. Chiral HPLC is the gold standard for ee determination because it is direct, does not require a reference sample, and works for compounds with no significant optical rotation.

Polarimetry. The observed optical rotation of the sample is measured and compared to the known rotation of the pure enantiomer. This method requires a literature value for $[\alpha {]}_{\text{pure}}$ and is sensitive to solvent, temperature, and concentration. It is the traditional method but has been largely superseded by chiral HPLC for precise ee determination.

NMR with chiral shift reagents. A chiral lanthanide complex (e.g., Eu(hfc)${}_3$) is added to the NMR sample. The complex binds to the substrate, and the two enantiomers form diastereomeric complexes with different chemical shifts. The relative integration of the separated signals gives the ee directly. This method is convenient for routine measurements but requires a suitable binding site on the substrate.

Diastereomeric excess (de). When a reaction produces diastereomers rather than enantiomers, the selectivity is measured by the diastereomeric excess:

$$\text{de}=\frac{[\text{major diastereomer}]-[\text{minor diastereomer}]}{[\text{major}]+[\text{minor}]}\times 100\%.$$

Unlike ee, de can be measured directly by conventional (achiral) HPLC or by NMR, because diastereomers have different physical properties. The de is important in reactions that form a new stereocentre in the presence of an existing one (diastereoselective reactions), where the existing stereocentre biases the facial selectivity of the new bond formation.

The relationship between stereoselectivity and reaction mechanism is diagnostic. High enantioselectivity (ee above 90%) in a catalytic reaction implies a well-organised transition state with a clear steric or electronic differentiation between the two enantiotopic faces. Low enantioselectivity (ee below 20%) implies either a poorly differentiated transition state or competing pathways with opposite facial selectivity. The absolute configuration of the major product, combined with computational modelling of the transition state, is the standard method for assigning the stereochemical course of asymmetric reactions.

Synthesis. Putting these together, the stereochemical framework -- from CIP descriptors through atropisomerism to asymmetric catalysis -- provides a unified language for describing molecular three-dimensional structure and its consequences for reactivity and biological function. The foundational reason chirality matters in chemistry is that biological systems are chiral environments, and this is exactly what makes enantioselective synthesis a pharmacological necessity. The bridge between static stereochemical descriptors and dynamic reaction outcomes appears again in 15.04.02 pending where the SN1/SN2 stereochemical signatures (inversion vs racemisation) are predicted from the framework established here. This pattern recurs throughout organic chemistry: every reaction creates, destroys, or modifies stereocentres, and the taxonomy of stereospecificity versus stereoselectivity generalises to any transformation involving chiral or prochiral centres. The central insight is that chirality is not a special property of certain molecules but a universal consequence of tetrahedral geometry with asymmetric substitution, and the framework developed here -- CIP priority, enantiomer/diastereomer classification, ee/de measurement, prochirality, and atropisomerism -- is the operational vocabulary for describing all of it.

Connections [Master]

• Hybridization and 3D shapes 14.02.02 pending. Supplies the tetrahedral geometry of sp${}^3$ carbon that underpins the stereocentre concept. The 109.5 degree bond angles and the non-planarity of tetrahedral carbon are what make chirality at carbon possible.

• SN1 vs SN2 substitution mechanisms 15.04.02 pending. SN2 produces inversion (Walden inversion) at the reacting stereocentre; SN1 produces racemisation. The stereochemical outcomes are direct applications of the definitions in this unit, and the stereospecificity of SN2 is one of the most powerful mechanistic diagnostics in organic chemistry.

• Electrophilic addition to alkenes 15.05.01. Addition reactions to alkenes create new stereocentres. Syn and anti addition have defined stereochemical consequences (e.g., anti addition of Br${}_2$ to an alkene gives a specific diastereomeric product). The R/S language from this unit is needed to describe the products.

• Carbonyl chemistry 15.07.01. Nucleophilic addition to a chiral aldehyde or ketone is governed by Cram's rule and the Felkin-Anh model, which predict facial selectivity based on the existing stereocentre's configuration. The prochirality (Re/Si face) concepts developed here are the descriptive framework for those predictions.

• Enzyme mechanism 17.05.01 pending. Enzymes are chiral catalysts that operate on prochiral substrates with high facial selectivity. The enantiotopic/diastereotopic distinction from this unit is the structural basis for enzymatic stereoselectivity, and the Re/Si face designation describes the trajectory of nucleophilic attack in enzyme active sites.

Historical & philosophical context [Master]

The discovery of molecular chirality is attributed to Louis Pasteur, who in 1848 manually separated the two crystal forms of sodium ammonium tartrate using a microscope and showed that the two forms rotated plane-polarised light in opposite directions ^{[Pasteur1848]}. Pasteur's experiment connected macroscopic crystal shape to microscopic molecular handedness, though the molecular structure explanation had to await the tetrahedral carbon hypothesis of van't Hoff and Le Bel (1874, independently) ^{[VantHoff1874] [LeBel1874]}.

Jacobus van't Hoff's pamphlet Voorstel tot uitbreiding der tegenwoordige in de scheikunde gebruikte structuur-formules in de ruimte (1874) extended structural formulae into three dimensions and predicted the optical activity of compounds with asymmetric carbon. The proposal was initially ridiculed -- Hermann Kolbe called it a "childish fantasy" -- but was rapidly confirmed by experiment. Van't Hoff received the first Nobel Prize in Chemistry (1901) for this and related contributions to chemical thermodynamics.

The CIP priority rules were developed by Robert Cahn, Christopher Ingold, and Vladimir Prelog in a 1966 paper that provided a systematic, unambiguous method for assigning R/S and E/Z descriptors ^{[CahnIngoldPrelog1966]}. The rules replaced a patchwork of ad hoc conventions (D/L system for sugars and amino acids, cis/trans for alkenes) with a single hierarchical algorithm. Prelog received the Nobel Prize in 1975 for his work on stereochemistry.

The development of asymmetric synthesis -- the ability to build a single enantiomer from achiral starting materials using a chiral catalyst -- transformed stereochemistry from a descriptive science into a synthetic one. The 2001 Nobel Prize in Chemistry, shared by Knowles, Noyori, and Sharpless, recognised three decades of work that moved asymmetric catalysis from laboratory curiosity to industrial practice. Knowles's asymmetric hydrogenation of L-DOPA (1975) was the first industrial application; Noyori's BINAP catalysts and Sharpless's epoxidation followed in the 1980s and became the workhorses of pharmaceutical synthesis ^{[Knowles2002] [Noyori2002] [Sharpless2002]}.

The philosophical significance of chirality is substantial. Molecular chirality demonstrates that handedness is a physical property, not merely a linguistic convenience: left-handed and right-handed molecules interact differently with other chiral entities (biological receptors, polarised light). The question of why biological systems use L-amino acids and D-sugars exclusively (biological homochirality) remains open. Proposed explanations range from weak nuclear parity violation (the V-A theory predicts a tiny energy difference between enantiomers) to autocatalytic amplification of a small initial enantiomeric excess. The Soai reaction (1995) demonstrates autocatalytic amplification in the laboratory: a pyrimidyl alcohol with initial ee below 0.1% amplifies to above 99% ee over a few catalytic cycles ^[Soai1995]. The origin of biological homochirality is a question at the intersection of chemistry, physics, and the origin of life.

Bibliography [Master]

Founding papers.

• Pasteur, L., "Memoire sur la relation qui peut exister entre la forme crystalline et la composition chimique", Ann. Chim. Phys. 24 (1848), 442--459.
• van't Hoff, J. H., Voorstel tot uitbreiding der tegenwoordige in de scheikunde gebruikte structuur-formules in de ruimte (Utrecht, 1874).
• Le Bel, J. A., "Sur les relations qui existent entre les formules atomiques des corps organiques et le pouvoir rotatoire de leurs dissolutions", Bull. Soc. Chim. Fr. 22 (1874), 337--347.

CIP rules and systematic stereochemistry.

• Cahn, R. S., Ingold, C. K. & Prelog, V., "Specification of Molecular Chirality", Angew. Chem. Int. Ed. 5 (1966), 385--415.
• Prelog, V. & Helmchen, G., "Basic Principles of the CIP-System and Proposals for a Revision", Angew. Chem. Int. Ed. 21 (1982), 567--583.

Textbook and monograph references.

• Eliel, E. L. & Wilen, S. H., Stereochemistry of Organic Compounds (Wiley, 1994).
• Clayden, J., Greeves, N. & Warren, S., Organic Chemistry, 2nd ed. (Oxford UP, 2012), Ch. 14--16.
• Anslyn, E. V. & Dougherty, D. A., Modern Physical Organic Chemistry (University Science Books, 2006), Ch. 6.
• Smith, M. B., March's Advanced Organic Chemistry, 7th ed. (Wiley, 2013), Ch. 5.

Asymmetric synthesis (Nobel lectures).

• Knowles, W. S., "Asymmetric Hydrogenations", Angew. Chem. Int. Ed. 41 (2002), 1998--2007.
• Noyori, R., "Asymmetric Catalysis: Science and Opportunities", Angew. Chem. Int. Ed. 41 (2002), 2008--2022.
• Sharpless, K. B., "Searching for New Reactivity (Nobel Lecture)", Angew. Chem. Int. Ed. 41 (2002), 2024--2032.

Origin of biological homochirality.

• Soai, K., Shibata, T., Morioka, H. & Choji, K., "Asymmetric Autocatalysis and Amplification of Enantiomeric Excess of a Chiral Molecule", Nature 378 (1995), 767--768.